Announcements Trials

Browse Landscape

Phase

Status

Sponsor Class

Study Type

Interventional 1

Sponsor

Conditions

Malignant mesenchymal tumor 1 Colorectal Neoplasms 1 Carcinoma 1

Interventions

Carboplatin 27 Paclitaxel 23 Cisplatin 22 Gemcitabine 17 pembrolizumab 15 Fluorouracil 9 Pemetrexed 8 Everolimus 8 Docetaxel 8 Cetuximab 8 Radiotherapy, Intensity-Modulated 7 Radiotherapy 7 130-nm albumin-bound paclitaxel 7 Sorafenib 6 Nivolumab 6 Bevacizumab 6 Axitinib 6 epothilone B 5 Sunitinib 5 Radiation 5 Panitumumab 5 Cyclophosphamide 5 trebananib 4 reolysin 4 padeliporfin 4 lenvatinib 4 Irinotecan 4 Gefitinib 4 vosaroxin 3 volociximab 3

Date Range

30 days 90 days 1 year All

Options

Has results Has announcements

Clinical Trials

1 trials

Recent Start date Enrollment

Completed × Carcinoma × NHS-IL12 immunocytokine × Clear all

NCT01417546 2021-10-18

NHS-IL12 for Solid Tumors

National Institutes of Health Clinical Center (CC)

Phase 1 Completed

Malignant mesenchymal tumor, Carcinoma

Data powered by HemOnc (CC BY 4.0) Colophon ⚡